EUVIMEDEUVIMED entdecken
Open Access

A potent proresolving mediator 17R-resolvin D2 from human macrophages, monocytes, and saliva

Mélissa Simard iD, Robert Nshimiyimana iD, Nan Chiang iD, Ana R Rodriguez iD, Bernd W Spur iD, Charles N Serhan iD

Science Advances · 2024

DOI: 10.1126/sciadv.adq4785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Mélissa Simard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospi…. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Macrophages, Saliva, Monocytes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Production of specialized proresolving mediators (SPMs) during the resolution phase in the acute inflammatory response is key to orchestrating complete resolution. Here, we uncovered a trihydroxy resolvin in fresh human saliva. We identified and determined its complete stereochemistry as 7S,16R,17R-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid (17R-RvD2) using total organic synthesis and matching of physical properties. The 17R-RvD2 was produced by activated human M2-like macrophages, M1-like macrophages, and human peripheral blood monocytes. 17R-RvD2 displayed potent proresolving functions (picomolar to nanomolar). Topical application of 17R-RvD2 on mouse ear skin reduced neutrophilic infiltration (~50%). 17R-RvD2 increased M2 markers CD206 and CD163 on human monocyte–derived macrophages and enhanced efferocytosis of senescent red blood cells by M2-like macrophages (EC 50 ~ 2.6 × 10 −14 M). In addition, 17R-RvD2 activated the RvD2 receptor and was equipotent to its epimer RvD2. 17R-RvD2 also significantly increased phagocytosis of Escherichia coli by human neutrophils. Together, these results establish the complete stereochemistry and potent proresolving functions of the previously unknown 17R-RvD2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Docosahexaenoic AcidsMacrophagesSalivaMonocytesHumansAnimalsMicePhagocytosisNeutrophils

Substanzen

Docosahexaenoic Acidsresolvin D2

Autor:innen und Institutionen

  • Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
  • Department of Cell Biology and Neuroscience, Virtua Health College of Medicine & Life Sciences of Rowan University, Stratford, NJ 08084, USA.

ORCID-Profile: Mélissa Simard, Robert Nshimiyimana, Nan Chiang, Ana R Rodriguez, Bernd W Spur, Charles N Serhan

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Simard, M., Nshimiyimana, R., Chiang, N., Rodriguez, A. R., Spur, B. W., & Serhan, C. N. (2024). A potent proresolving mediator 17R-resolvin D2 from human macrophages, monocytes, and saliva. Science Advances. https://doi.org/10.1126/sciadv.adq4785

Vancouver

Simard M, Nshimiyimana R, Chiang N, Rodriguez AR, Spur BW, Serhan CN. A potent proresolving mediator 17R-resolvin D2 from human macrophages, monocytes, and saliva. Science Advances. 2024. doi:10.1126/sciadv.adq4785

BibTeX
@article{Simard2024,
  author = {Simard, Mélissa and Nshimiyimana, Robert and Chiang, Nan and Rodriguez, Ana R and Spur, Bernd W and Serhan, Charles N},
  title = {A potent proresolving mediator 17R-resolvin D2 from human macrophages, monocytes, and saliva},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adq4785}
}
Kostenlos starten →